NeuroNexus is a fast-growing neurotechnology company that develops and commercializes high-value neural interface technology, components, systems, and software for neuroscience and clinical applications. Originally developed at the University of Michigan, NeuroNexus’ suite of commercialized technologies has, for over a decade, led to hundreds of publications from research labs all around the world. Our products include conventional and high-density leads, recording and stimulation systems, and software for data analytics. Our products have been used in a wide variety of animal models from fruit fly to rodent to non-human primates. NeuroNexus is currently working to make our state-of-the-art technologies and systems available for human clinical research. NeuroNexus’ proprietary microelectronic, fluidic, and optical technology is used to “map” brain function, detect neural activity, and stimulate or modulate neural circuits when brain function is impaired. NeuroNexus is a subsidiary of Nuvectra, and is located in Ann Arbor, Michigan, USA.
NeuroNexus Standard Probes are fabricated using state-of-the-art silicon MEMs technology, originally developed at the University of Michigan. Standard Probes are used in labs worldwide for single unit, multiple unit, and local field potential (LFP) recording and stimulation, in acute and chronic applications.
NeuroNexus ECoG probes are ultra-flexible surface grids with high recording resolution, designed to conform closely to the brain surface for electrocorticography. Flexible and Durable – Fabricated with our polymer MEMS technology, our ECoG probes can conform to the brain surface. Optimized array designs – Select from a variety of ECoG array designs featuring different site spacings, for different applications…
